Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 35 | ECE2014 | Next issue

16th European Congress of Endocrinology

Oral Communications

Diabetes and Obesity 1

ea0035oc4.1 | Diabetes and Obesity 1 | ECE2014

The lower postprandial glucose oxidation in nondiabetic carriers of risk variants of TCF7L2 gene

Adamska Edyta , Kretowski Adam , Goscik Joanna , Waszczeniuk Magdalena , Wawrusiewicz-Kurylonek Natalia , Citko Anna , Ciborowski Michal , Maliszewska Katarzyna , Gorska Maria

Introduction: The transcription factor 7-like 2 gene (TCF7L2) has the strongest effect on the risk of type 2 diabetes but the mechanism for this is not fully understood. Some genetic variants are associated with pancreatic B-cell function and some single nucleotide polymorphisms show a significant correlation with obesity. The aim of the study was to analyze whether TCF7L2 variants may influence body weight and body fat content, as well as postprandial glucose metabolism in no...

ea0035oc4.2 | Diabetes and Obesity 1 | ECE2014

Vildagliptin alone, and in half-dose combination with metformin, attenuates streptozotocin-induced diabetic nephropathy in high-fat fed heminephrectomized rats

Bayrasheva Valentina , Grineva Elena , Babenko Alina , Galagudza Michael , Chefu Svetlana , Dmitriev Yuri , Bairamov Alekber

Background: Presently, a great deal of attention is being paid to investigation of pleiotropic effects of oral antidiabetic drugs. Several recent animal studies have suggested that vildagliptin and metformin could play some positive role in preventing the evolvement of diabetic nephropathy.Aim: This pilot study, concerned with high-fat fed heminephrectomized streptozotocin (STZ)-induced diabetic rats, aimed to evaluate and compare the effects of metformi...

ea0035oc4.3 | Diabetes and Obesity 1 | ECE2014

Importance of neuropeptide Y as a predictor of nephropathy in type 2 diabetic patients

Unal Asli Dogruk , Tarcin Ozlem , Takir Mumtaz , Parildar Hulya , Cigerli Ozlem , Eroglu Hacer , Demirag Nilgun Guvener

Background and aims: Neuropeptide Y (NPY) cause decrease glomerular filtration rate, aldosterone concentration, and plasma renin activity by stimulating NPY receptors in the kidney. Previous studies have suggested that NPY polymorphism is related to development of advanced diabetic nephropathy (DN). The aim of this study was to evaluate the relationship between the serum neuropeptide Y levels and different stages of DN in patients with type 2 diabetes mellitus (T2DM).<p cl...

ea0035oc4.4 | Diabetes and Obesity 1 | ECE2014

Endothelial progenitor Cells exhibit decreased function but increased numbers in overt type 2 diabetic nephropathy

Liu Siying , Yan Shuang , Ji Zongshan , Yu Haiqiao , Cheng Weilun , Quan Wei

Background: Endothelial progenitor cells (EPCs) play an important role in neovascularization and endothelial regeneration, and the number and function of circulating EPCs is decreased in patients with diabetic retinopathy and type 1 diabetic nephropathy. However, the number and function of EPCs in patients with type 2 diabetes nephropathy is unknown.Methods: Participants were divided into three groups: 1) type 2 diabetes with overt nephropathy (DN group,...

ea0035oc4.5 | Diabetes and Obesity 1 | ECE2014

A comparison of lipoprotein associated phospholipase A2 and high sensitive C-reactive protein levels between diabetic and non-diabetic patients with coronary artery disease

Das Saswati , Gupta SK , MP Girish , Ray PC

Background: Lipoprotein-associated phospholipase A2 (LpPLA2) is known as an emerging marker of coronary artery disease (CAD). However its role and levels have not been documented clearly in diabetic patients with CAD in Indians. The aim of this study was to explore the association of LpplA2 levels between diabetic and non-diabetic patients with CAD and compare it with other established markers like hs-CRP.Methods: Sixty individuals with angiographically ...